Craneware plc Posting of Annual Report and Notice of AGM (7500D)
October 11 2018 - 5:50AM
UK Regulatory
TIDMCRW
RNS Number : 7500D
Craneware plc
11 October 2018
11 October 2018
Craneware plc
("Craneware" or the "Company")
Posting of Annual Report and Notice of AGM
The Company's 2018 Annual Report has been posted to shareholders
together with the Notice of Annual General Meeting and the
associated form of proxy. The Company's AGM will be held at the
offices of Peel Hunt LLP, 120 London Wall, London, EC2Y 5ET, UK, on
6 November 2018 at 1pm.
Among the resolutions will be the declaration of a final
dividend for the year ended 30 June 2018 of 14.0 pence per share
giving a total dividend for the year of 24.0 pence per share. The
final dividend will be paid on 6 December 2018 to shareholders on
the register as at 9 November 2018, with a corresponding
ex-Dividend date of 8 November 2018.
The final dividend of 14.0 pence per share is capable of being
paid in US dollars subject to a shareholder having registered to
receive their dividend in US dollars under the Company's Dividend
Currency Election, or who register to do so by the close of
business on 9 November 2018. The exact amount to be paid will be
calculated by reference to the exchange rate to be announced on 9
November 2018.
The Annual Report, the Notice of AGM and related documents are
available on the Company's website at www.craneware.com
For further information, please contact:
Craneware plc Peel Hunt (NOMAD & Joint Investec Bank (Joint Alma (Financial PR)
Broker) Broker)
+44 (0)131 550
3100 +44 (0)20 7418 8900 +44 (0)20 7597 5970 +44 (0)208 004 4217
Keith Neilson, Dan Webster Patrick Robb Caroline Forde
CEO
Craig Preston, George Sellar Sebastian Lawrence Robyn Fisher
CFO Guy Pengelley Henry Reast Josh Royston
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated Value Cycle solutions that
help US Healthcare provider organisations discover, convert and
optimise assets to achieve best clinical outcomes and financial
performance. Founded in 1999, Craneware is headquartered in
Edinburgh, Scotland with offices in Atlanta and Pittsburgh
employing over 320 staff. Craneware's market-driven, SaaS solutions
normalise disparate data sets, bringing in up-to-date regulatory
and financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOAKFLBFVBFZFBZ
(END) Dow Jones Newswires
October 11, 2018 05:50 ET (09:50 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024